Health Catalyst Announces Closing of Initial Public Offering a... - 30 July 2019 07:20

SALT LAKE CITY, July 30, 2019 /PRNewswire-AsiaNet/ -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the closing of its initial public offering of 8,050,000 shares of its common sto...

  Internationally Renowned Radiation Oncologist, Prof. Dr. Datta... - 30 July 2019 00:15

NEW DELHI, July 29, 2019 /PRNewswire-AsiaNet/ -- Apollo Hospitals have appointed world renowned Radiation Oncologist, Prof. Dr. Dattatreyudu Nori, as International Director – Apollo Cancer Centres, Apollo Hospitals Group. Beginning this month, Dr. Nori will be available for consultations 10 ...

  Alvotech and Cipla Gulf Enter Into a Partnership for the Comme... - 29 July 2019 14:00

REYKJAVIK, Iceland and MUMBAI, India, July 29, 2019 /PRNewswire-AsiaNet/ -- Biopharmaceutical company Alvotech and Cipla Gulf FZ LLC ("Cipla Gulf"), a wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited (BSE: 500087) (NSE: CIPLA EQ; hereafter referred to as "Cipla"), today announced that Alv...

  Expanded FluidX Next-Gen Sample Tube Range – the most comprehe... - 26 July 2019 00:19

CHELMSFORD, Mass., July 26, 2019 /PRNewswire-AsiaNet/ -- Brooks Life Sciences expanded the FluidX Next-Gen Sample Tube range, providing flexibility through the widest range of coded sample tubes available in the industry. Comprising of 18 sample tubes - you have the flexibility of choosing a tube that f...

  Penta and CROMSOURCE Announce Their Partnership to Improve Pae... - 25 July 2019 21:00

VERONA, Italy, July 25, 2019 /PRNewswire-AsiaNet / -- Penta ID Innovation, a recently established SMO stemmed from the Penta Global Paediatric Research Network, and CROMSOURCE, an international contract research organization (CRO) providing a comprehensive portfolio of services to the pharmaceutical,...

  NanoCellect Biomedical Expands Distribution to Australia and N... - 25 July 2019 00:39

SAN DIEGO, California, July 25, 2019 /PRNewswire-AsiaNet/ -- - Company enters exclusive agreement with Millennium Science Pty Ltd NanoCellect Biomedical Inc., a leader in the development and manufacture of microfluidic cell sorting solutions for cell-based assays, today announced an exclusive agree...

  Verb Surgical Announces Kurt Azarbarzin as President and CEO - 24 July 2019 23:00

MOUNTAIN VIEW, California, July 24, 2019 /PRNewswire-AsiaNet/ -- Verb Surgical Inc. today announced that Kurt Azarbarzin has joined the company as President and Chief Executive Officer, effective immediately. Logo - https://mma.prnewswire.com/media/613687/verb_surgical_Logo.jpg "I am incredibly honored an...

  Announcing 3B SMART ANATOMY – The New Generation of Anatomical... - 24 July 2019 04:36

HAMBURG, Germany, July 24, 2019 /PRNewswire-AsiaNet/ -- Today, 3B Scientific introduced to the global market 3B SMART ANATOMY, a new generation of anatomical models. 3B SMART ANATOMY is designed to close the gap between analog and digital learning. Virtual meets Reality – the concept of 3B SMART ANA...

  SINOMED(R) Concludes Enrollment of the PIONEER III Randomized,... - 23 July 2019 17:00

TIANJIN, China, July 23, 2019 /PRNewswire-AsiaNet/ -- North America, Europe and Japan trial seeks approval for the US and Japanese markets In a significant milestone toward obtaining key regulatory approvals for the BuMA Supreme Drug-Eluting Stent (DES) System, SINOMED has completed enrollment in ...

  Kazia to test GDC-0084 with Radiotherapy in Phase I Clinical T... - 22 July 2019 11:50

SYDNEY, July 22, 2019 /PRNewswire-AsiaNet/-- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that Memorial Sloan Kettering Cancer Center (MSK) in New York, NY will investigate the potential use of Kazia's inves...